Literature DB >> 19621379

Analysis of gamma-globulin mobility on routine clinical CE equipment: exploring its molecular basis and potential clinical utility.

Dieter Vanderschaeghe1, Evi Debruyne, Hans Van Vlierberghe, Nico Callewaert, Joris Delanghe.   

Abstract

A study was conducted on the variability of gamma-globulin mobility in serum protein electrophoresis and its molecular basis. We found that the migration time of gamma-globulins can be reproducibly determined (CV=1.1%) on clinical CE equipment. Moreover, we found a significant difference (p<0.001) in the migration of gamma-globulins between chronic liver disease patients (n=98) and a healthy reference group (n=47). Serum immunoglobulins were purified from these patients' sera using protein L-agarose and their glycosylation was studied using CE on a DNA sequencer. This glycomics approach revealed that several non-sialylated N-glycans show a moderate Pearson correlation coefficient (r=0.2-0.4) with the migration time of gamma-globulins. Their sialylated structures correlate negatively (r=-0.2 to -0.3). Immunoglobulins are significantly more sialylated in the healthy reference group compared with the patients (p<0.001). We estimated that sialylation heterogeneity contributes about 36% to the molecular variance (carbohydrates and amino acid composition) that affects the electrophoretic mobility of immunoglobulins. This is the first report on the migration time of gamma-globulins on a clinical CE instrument and its potential clinical value to the routinely analyzed serum protein CE profiles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621379     DOI: 10.1002/elps.200900054

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

1.  Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach.

Authors:  L Veillon; S Zhou; Y Mechref
Journal:  Methods Enzymol       Date:  2017-01-09       Impact factor: 1.600

Review 2.  Quantitative glycomics strategies.

Authors:  Yehia Mechref; Yunli Hu; Janie L Desantos-Garcia; Ahmed Hussein; Haixu Tang
Journal:  Mol Cell Proteomics       Date:  2013-01-16       Impact factor: 5.911

3.  Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.

Authors:  Petr Pompach; Zuzana Brnakova; Miloslav Sanda; Jing Wu; Nathan Edwards; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.